Cytokinetics EBIT 2010-2024 | CYTK

Cytokinetics EBIT for the quarter ending September 30, 2024 was $-0.141B, a 15.16% increase year-over-year.

  • Cytokinetics 2023 EBIT was -0.496B, a 53.05% increase from 2022.
  • Cytokinetics 2022 EBIT was -0.324B, a 74.01% increase from 2021.
  • Cytokinetics 2021 EBIT was -0.186B, a 98.33% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Cytokinetics EBIT 2010-2024 | CYTK

  • Cytokinetics 2023 EBIT was -0.496B, a 53.05% increase from 2022.
  • Cytokinetics 2022 EBIT was -0.324B, a 74.01% increase from 2021.
  • Cytokinetics 2021 EBIT was -0.186B, a 98.33% increase from 2020.

EBIT can be defined as earnings before interest and taxes.